InsiderTrades.com logo

OKUR Insider Trading

Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,416,923.23

OnKure Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at OnKure Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OnKure Therapeutics Share Price & Price History

Current Price: $2.63
Price Change: ▲ Price Increase of +0.01 (0.38%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for OKUR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

OnKure Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2025Jason A LeveroneCFOSell303$2.62$793.8612,603View SEC Filing Icon  
9/22/2025Nicholas A SaccomanoCEOSell88$2.62$230.563,506View SEC Filing Icon  
6/23/2025Jason A LeveroneCFOSell303$2.38$721.1412,906View SEC Filing Icon  
6/23/2025Nicholas A SaccomanoCEOSell88$2.38$209.443,594View SEC Filing Icon  
5/15/2025Cormorant Asset Management, LpMajor ShareholderSell1,813,439$1.85$3,354,862.15View SEC Filing Icon  
5/12/2025Cormorant Asset Management, LpMajor ShareholderSell24,300$1.99$48,357.001,813,439View SEC Filing Icon  
4/7/2025Jason A LeveroneCFOSell1,844$2.67$4,923.4813,209View SEC Filing Icon  
4/7/2025Nicholas A SaccomanoCEOSell516$2.67$1,377.723,682View SEC Filing Icon  
4/4/2025Jason A LeveroneCFOSell1,278$3.33$4,255.7415,053View SEC Filing Icon  
4/4/2025Nicholas A SaccomanoCEOSell358$3.33$1,192.144,198View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for OnKure Therapeutics (NASDAQ:OKUR)

90.98% of OnKure Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OKUR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

OnKure Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/1/2025Cantor Fitzgerald L. P.491,863$1.35M0.0%-26.5%3.631%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC1,016,613$2.80M0.0%-6.7%7.503%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.491,863$1.35M0.0%-26.5%3.630%Search for SEC Filing on Google Icon
11/14/2025Shay Capital LLC917,934$2.52M0.2%+17.4%6.784%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC19,500$54K0.0%-22.0%0.144%Search for SEC Filing on Google Icon
11/14/2025Prosight Management LP267,959$0.74M0.2%+67.8%1.980%Search for SEC Filing on Google Icon
11/10/2025Highbridge Capital Management LLC650,218$1.79M0.1%-2.0%4.806%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP59,224$0.16M0.0%+172.1%0.438%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.678,226$1.87M0.0%-4.0%5.013%Search for SEC Filing on Google Icon
8/15/2025Shay Capital LLC782,046$1.87M0.2%+417.8%5.789%Search for SEC Filing on Google Icon
8/15/2025Rangeley Capital LLC29,902$71K0.1%N/A0.221%Search for SEC Filing on Google Icon
8/15/2025Acorn Capital Advisors LLC2,839,674$6.79M4.4%+97.2%21.019%Search for SEC Filing on Google Icon
8/13/2025Affinity Asset Advisors LLC347,990$0.83M0.1%-11.7%2.576%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd10,643$25K0.0%N/A0.079%Search for SEC Filing on Google Icon
8/12/2025Highbridge Capital Management LLC663,607$1.59M0.1%+51.2%4.912%Search for SEC Filing on Google Icon
8/8/2025Bailard Inc.14,239$34K0.0%N/A0.105%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC10,000$43K0.0%N/A0.074%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC394,159$1.70M0.2%+173.4%2.934%Search for SEC Filing on Google Icon
2/17/2025Vestal Point Capital LP635,000$5.46M0.3%N/A19.012%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP14,228$0.12M0.0%N/A0.426%Search for SEC Filing on Google Icon
2/17/2025Tang Capital Management LLC294,626$2.53M0.2%N/A8.821%Search for SEC Filing on Google Icon
2/17/2025Shay Capital LLC15,016$0.13M0.0%N/A0.450%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.87,354$0.75M0.1%N/A2.615%Search for SEC Filing on Google Icon
2/17/2025Prosight Management LP63,754$0.55M0.2%N/A1.909%Search for SEC Filing on Google Icon
2/17/2025OMERS ADMINISTRATION Corp12,100$0.10M0.0%N/A0.362%Search for SEC Filing on Google Icon
2/17/2025NEA Management Company LLC478,548$4.12M0.2%N/A14.328%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC144,099$1.24M0.0%N/A4.314%Search for SEC Filing on Google Icon
2/17/2025Deep Track Capital LP523,989$4.51M0.2%N/A15.688%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC20,549$0.18M0.0%N/A0.615%Search for SEC Filing on Google Icon
2/17/2025Cantor Fitzgerald L. P.35,700$0.29M0.0%N/A1.069%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC1,074,314$8.78M0.0%N/A32.165%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE249,642$2.15M0.0%N/A7.474%Search for SEC Filing on Google Icon
2/17/2025683 Capital Management LLC43,371$0.37M0.0%N/A1.299%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC1,439,674$12.38M6.8%N/A43.104%Search for SEC Filing on Google Icon
2/14/2025Samsara BioCapital LLC824,155$7.09M1.0%N/A24.675%Search for SEC Filing on Google Icon
2/14/2025Nantahala Capital Management LLC54,777$0.47M0.0%N/A1.640%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp19,177$0.17M0.0%N/A0.574%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC78,021$0.67M0.0%N/A2.336%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC218,386$1.88M0.5%N/A6.539%Search for SEC Filing on Google Icon
2/13/2025Affinity Asset Advisors LLC144,159$1.24M0.2%N/A4.316%Search for SEC Filing on Google Icon
2/13/2025Carlyle Group Inc.269,895$2.33M0.5%N/A8.081%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC13,495$0.12M0.0%N/A0.404%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd18,633$0.16M0.0%N/A0.558%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC8,741$75K0.0%N/A0.262%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC47,450$0.41M0.0%N/A1.421%Search for SEC Filing on Google Icon
2/12/2025Aldebaran Capital LLC45,572$0.39M0.4%N/A1.363%Search for SEC Filing on Google Icon
2/12/2025Aisling Capital Management LP88,607$0.76M0.3%N/A2.651%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC76,599$0.66M0.0%N/A2.291%Search for SEC Filing on Google Icon
2/12/2025Highbridge Capital Management LLC399,743$3.44M0.1%N/A11.958%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
OnKure Therapeutics logo
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Read More on OnKure Therapeutics

Today's Range

Now: $2.63
Low: $2.58
High: $2.74

50 Day Range

MA: $2.95
Low: $2.51
High: $3.57

52 Week Range

Now: $2.63
Low: $1.70
High: $15.89

Volume

49,670 shs

Average Volume

128,528 shs

Market Capitalization

$35.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of OnKure Therapeutics?

OnKure Therapeutics' top insider shareholders include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Jason A Leverone (CFO)
  3. Nicholas A Saccomano (CEO)
Learn More about top insider investors at OnKure Therapeutics.

Who are the major institutional investors of OnKure Therapeutics?

OnKure Therapeutics' top institutional shareholders include:
  1. Citadel Advisors LLC — 7.50%
  2. Shay Capital LLC — 6.78%
  3. Vanguard Group Inc. — 5.01%
  4. Highbridge Capital Management LLC — 4.81%
  5. Cantor Fitzgerald L. P. — 3.63%
  6. Cantor Fitzgerald L. P. — 3.63%
Learn More about top institutional investors of OnKure Therapeutics stock.

Which major investors are selling OnKure Therapeutics stock?

In the last quarter, OKUR stock was sold by these institutional investors:
  1. Cantor Fitzgerald L. P.
  2. Cantor Fitzgerald L. P.
  3. Citadel Advisors LLC
  4. Vanguard Group Inc.
  5. Highbridge Capital Management LLC
  6. Bridgeway Capital Management LLC
During the last year, company insiders that have sold OnKure Therapeutics company stock include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Jason A Leverone (CFO)
  3. Nicholas A Saccomano (CEO)
Learn More investors selling OnKure Therapeutics stock.

Which major investors are buying OnKure Therapeutics stock?

During the last quarter, OKUR stock was acquired by institutional investors including:
  1. Shay Capital LLC
  2. Prosight Management LP
  3. GSA Capital Partners LLP